Grant: Discovery Grants Program - Individual
University of British Columbia
$41,000.00
The development of advanced imaging and dosimetry for permanent breast seed implant radiation therapy
FY 2021-22
Summary
An estimated 27,000 Canadian women will be diagnosed with breast cancer in 2020. The treatment, surgery followed by 3.5 to 7 weeks of daily radiation therapy (RT), presents a significant burden to both our health care system and our patients. In fact, patients in remote communities may not complete their RT due to challenges in undertaking treatment far from home. Permanent breast seed implant (PBSI) is a novel, effective, breast RT that is undertaken in a single day, thereby significantly reducing the healthcare burden. My research program is focused on developing novel imaging and dosimetry tools and techniques to help enable PBSI across Canada. PBSI is administered by implanting radioactive seeds into the breast under two-dimensional ultrasound (2DUS) imaging guidance. While effective, PBSI is technically challenging and my research group has pioneered the development of technology and dose analysis tools to increase the precision and robustness of PBSI. We were the first to quantify the uncertainty in implant delivery and to discover that US clarity impacts implant accuracy. We have developed methodologies for accurately recording skin dose (a risk for treatment toxicity) and target doses post-operatively. In collaboration with Robarts Imaging we have developed a non-clinical prototype 3DUS scanner for PBSI. Here we build on this work to address primary bottlenecks in PBSI imaging, precision, individualized targeting, and quantitative post-implant dosimetry. The aims of this proposal are: Aim 1: 3DUS based PBSI: Long-term: To develop a fully 3DUS-based PBSI technique. Five-year: To develop and verify 3DUS technology for PBSI target delineation and implant guidance, thereby enabling improved treatment accuracy over existing protocols. Aim 2: Individualized targeting: Long-term: To develop methodology for personalized, precision, PBSI. Five-year: To model uncertainties in implant delivery and establish individualized margins for PBSI targeting, thereby enabling high precision, individualized targeting of PBSI treatments. Aim 3: Accurate post-implant dosimetry: Long-term: To develop quantitative dosimetry systems for accurate dose-outcome analysis. Five-year: To model the dosimetric impacts of seed movement, skin delineation, and breast shielding on skin dose, and to experimentally determine the impact of breast position on treatment dose. The result will be improved accuracy of post-implant dose analysis over current methodologies. This work will establish a technical framework to enable precise, image-guided, individualized, adaptive PBSI and ultimately support my long-term research goal to ensure the availability of single day breast cancer radiation treatment across Canada. My work will also positively impact Canada's future by training a diverse group of 5 HQP to be medical physics leaders in academia, hospitals, or industry. As a mentor for young women, my HQP training will help address the gender imbalance in our field.
Program
Discovery Grants Program - Individual
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2021-02623
Name nom
Hilts, Michelle
Department département
Medical Physics
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2021
Award amount
41000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1505
Committee name en
Physics
Committee name fr
Physique
Area of application code
1202
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Physical sciences
Area of application fr
Sciences physiques
Research subject code
3114
Research subject group en
Physics
Research subject group fr
Physique
Research subject en
Biological and Medical Physics
Research subject fr
Physique biologique et médicale
Installment
inst:1
Partie
1
Nb partie
5
Application title
The development of advanced imaging and dosimetry for permanent breast seed implant radiation therapy
Keyword
NSERC
Application summary
An estimated 27,000 Canadian women will be diagnosed with breast cancer in 2020. The treatment, surgery followed by 3.5 to 7 weeks of daily radiation therapy (RT), presents a significant burden to both our health care system and our patients. In fact, patients in remote communities may not complete their RT due to challenges in undertaking treatment far from home. Permanent breast seed implant (PBSI) is a novel, effective, breast RT that is undertaken in a single day, thereby significantly reducing the healthcare burden. My research program is focused on developing novel imaging and dosimetry tools and techniques to help enable PBSI across Canada. PBSI is administered by implanting radioactive seeds into the breast under two-dimensional ultrasound (2DUS) imaging guidance. While effective, PBSI is technically challenging and my research group has pioneered the development of technology and dose analysis tools to increase the precision and robustness of PBSI. We were the first to quantify the uncertainty in implant delivery and to discover that US clarity impacts implant accuracy. We have developed methodologies for accurately recording skin dose (a risk for treatment toxicity) and target doses post-operatively. In collaboration with Robarts Imaging we have developed a non-clinical prototype 3DUS scanner for PBSI. Here we build on this work to address primary bottlenecks in PBSI imaging, precision, individualized targeting, and quantitative post-implant dosimetry. The aims of this proposal are: Aim 1: 3DUS based PBSI: Long-term: To develop a fully 3DUS-based PBSI technique. Five-year: To develop and verify 3DUS technology for PBSI target delineation and implant guidance, thereby enabling improved treatment accuracy over existing protocols. Aim 2: Individualized targeting: Long-term: To develop methodology for personalized, precision, PBSI. Five-year: To model uncertainties in implant delivery and establish individualized margins for PBSI targeting, thereby enabling high precision, individualized targeting of PBSI treatments. Aim 3: Accurate post-implant dosimetry: Long-term: To develop quantitative dosimetry systems for accurate dose-outcome analysis. Five-year: To model the dosimetric impacts of seed movement, skin delineation, and breast shielding on skin dose, and to experimentally determine the impact of breast position on treatment dose. The result will be improved accuracy of post-implant dose analysis over current methodologies. This work will establish a technical framework to enable precise, image-guided, individualized, adaptive PBSI and ultimately support my long-term research goal to ensure the availability of single day breast cancer radiation treatment across Canada. My work will also positively impact Canada's future by training a diverse group of 5 HQP to be medical physics leaders in academia, hospitals, or industry. As a mentor for young women, my HQP training will help address the gender imbalance in our field.